Sarah Garner
Impact in
- Dermatology top 0.2%
- Acne and Rosacea Treatments and Effects
- Dermatology and Skin Diseases
- Skin Protection and Aging
- Dermatologic Treatments and Research
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 17
- Pharmaceutical Economics and Policy 13
-
- Healthcare cost, quality, practices 5
- Co-authors
- Hywel C Williams (1 shared paper)Robert P. Dellavalle (1 shared paper)Peter Littlejohns (5 shared papers)John Newton (2 shared papers)C Popescu (3 shared papers)E. Anne Eady (3 shared papers)Mike Clarke (2 shared papers)Jacoline C. Bouvy (2 shared papers)
- Journals
- Cochrane Database of Systematic Reviews (8 papers)International Journal of Technology Assessment in Health Care (4 papers)The Lancet (3 papers)Frontiers in Pharmacology (3 papers)BMJ Open (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Sarah Garner
56 papers receiving 2.4k citations
Sarah Garner's Hit Papers
Peers
Comparison fields: 5 of 155
- Dermatology 886
- Applied Microbiology and Biotechnology 38
- Molecular Medicine 64
- Economics and Econometrics 349
- General Health Professions 265
Countries citing papers authored by Sarah Garner
This map shows the geographic impact of Sarah Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Garner more than expected).
Fields of papers citing papers by Sarah Garner
This network shows the impact of papers produced by Sarah Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Garner. The network helps show where Sarah Garner may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Garner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acne vulgaris Hit paper breakdown → | 2011 | 827 |
| 2 | 2012 | 127 | |
| 3 | 2012 | 122 | |
| 4 | 2011 | 119 | |
| 5 | 2016 | 83 | |
| 6 | 2015 | 68 | |
| 7 | 2015 | 63 | |
| 8 | 1999 | 60 | |
| 9 | 2018 | 57 | |
| 10 | 2015 | 57 | |
| 11 | 2020 | 54 | |
| 12 | 2013 | 52 | |
| 13 | 2014 | 47 | |
| 14 | 2021 | 42 | |
| 15 | 2017 | 42 | |
| 16 | 2005 | 42 | |
| 17 | 2003 | 40 | |
| 18 | 2007 | 34 | |
| 19 | 2013 | 33 | |
| 20 | Disease Registers in England | 2002 | 31 |
About Sarah Garner
Sarah Garner is a scholar working on Economics and Econometrics, General Health Professions, Physiology, Molecular Biology and Pharmacology, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Pharmaceutical Economics and Policy (13 papers), Healthcare cost, quality, practices (5 papers), Acne and Rosacea Treatments and Effects (4 papers), Biomedical Ethics and Regulation (3 papers), HIV, Drug Use, Sexual Risk (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Crime, Illicit Activities, and Governance (3 papers). The work is most often cited by research in Dermatology (886 citations), Applied Microbiology and Biotechnology (38 citations), Molecular Medicine (64 citations), Economics and Econometrics (349 citations) and General Health Professions (265 citations). Sarah Garner has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Hywel C Williams, Robert P. Dellavalle, Peter Littlejohns, John Newton, C Popescu, E. Anne Eady, Mike Clarke, Jacoline C. Bouvy, Cathy Bennett and Axel Mühlbacher. Their work appears in journals such as Cochrane Database of Systematic Reviews, International Journal of Technology Assessment in Health Care, The Lancet, Frontiers in Pharmacology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.